Clover Health Investments Income Statement (2019-2025) | CLOV

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 165.50M172.08M169.07M166.23M200.32M412.47M427.16M432.04M874.38M846.70M856.82M-1481.34M321.99M320.14M306.03M312.38M346.92M356.26M330.99M336.96M462.33M477.62M496.65M
Cost of Revenue 146.33M119.37M144.85M179.54M214.42M458.50M436.32M441.93M861.72M858.79M839.80M-1567.23M274.79M244.26M235.78M249.75M265.16M248.35M249.77M243.04M353.44M377.99M423.47M
Gross Profit 19.18M52.72M24.22M-13.31M-14.10M-46.03M-9.16M-9.89M12.66M-12.09M17.02M85.89M47.20M75.88M70.24M62.63M81.76M107.91M81.21M93.92M108.89M99.63M73.18M
Operating items
Amortization - Intangibles -5.71M-4.82M-13.66M-0.01M
Selling, General & Administrative 28.48M21.47M29.85M41.03M38.62M45.65M45.85M55.18M57.70M47.04M47.83M51.11M57.64M41.71M41.03M42.70M44.57M44.42M35.20M52.29M50.67M48.48M48.95M
Other Operating Expenses 163.65M127.44M160.84M192.83M280.80M548.69M530.57M563.65M904.16M902.39M883.08M-1510.09M344.05M307.31M298.61M332.81M325.06M304.65M304.57M306.12M412.93M439.69M472.07M
Operating Expenses 192.13M148.91M190.69M233.86M319.41M594.33M576.42M618.83M961.86M949.43M930.91M-1458.98M401.69M349.02M339.64M375.52M369.62M349.07M339.77M358.41M463.61M488.18M521.03M
Operating Income -26.63M23.17M-21.62M-67.63M-119.09M-181.86M-149.25M-186.79M-87.48M-102.73M-74.10M-22.36M-79.70M-28.88M-33.62M-63.13M-22.70M7.19M-8.79M-21.45M-1.27M-10.56M-24.38M
EBIT -26.63M23.17M-21.62M-67.63M-119.09M-181.86M-149.25M-186.79M-87.48M-102.73M-74.10M-22.36M-79.70M-28.88M-33.62M-63.13M-22.70M7.19M-8.79M-21.45M-1.27M-10.56M-24.38M
Non-operating items
Non Operating Investment Income 12.39M-1.23M-0.98M-0.97M-4.73M-0.47M
Other Non Operating Income 14.23M5.16M68.08M6.28M
Net income details
EBT -34.45M14.69M-30.89M-78.06M-120.26M-183.07M-149.66M-187.19M-87.88M-103.12M-74.50M-22.50M-79.70M-28.89M-33.62M-63.13M-22.70M7.19M-8.79M-21.45M-1.27M-10.56M-24.38M
Profit After Tax -28.16M5.40M12.76M-126.39M-48.42M-317.61M-34.53M-187.20M-75.49M-104.36M-75.49M-84.23M-79.70M-28.89M-41.47M-70.47M-23.17M7.41M-9.15M-21.48M-1.27M-10.58M-24.38M
Income from Continuing Operations -34.45M14.69M-30.89M-78.06M-120.26M-183.07M-149.66M-187.19M-87.88M-103.12M-74.50M-22.50M-79.70M-28.89M-33.62M-63.13M-22.70M7.19M-8.79M-21.45M-1.27M-10.56M-24.38M
Consolidated Net Income -34.45M14.69M-30.89M-78.06M-120.26M-183.07M-149.66M-187.19M-87.88M-103.12M-74.50M-22.50M7.09M0.07M-7.85M-2.53M4.00M0.24M-0.40M-0.64M
Income towards Parent Company -34.45M14.69M-30.89M-78.06M-120.26M-183.07M-149.66M-187.19M-87.88M-103.12M-74.50M-22.50M7.09M0.07M-7.85M-2.53M4.00M0.24M-0.40M-0.64M
Net Income towards Common Stockholders -28.16M14.69M-30.89M-78.06M-48.42M-183.07M-149.66M-187.19M-87.88M-103.12M-74.50M-22.50M7.09M0.07M-7.85M-2.53M4.00M0.24M-0.40M-0.64M
Additional items
EPS (Basic) -0.320.020.06-1.43-0.13-0.78-0.08-0.44-0.16-0.22-0.160.01-0.17-0.06-0.07-0.14-0.050.01-0.020.00-0.02-0.05
EPS (Weighted Average and Diluted) 0.010.02-1.43-0.13-0.78-0.08-0.44-0.16-0.22-0.160.01-0.17-0.06-0.07-0.14-0.050.01-0.020.00-0.02-0.05
Shares Outstanding (Weighted Average) 87.83M88.33M88.61M88.86M88.69M376.17M408.16M414.57M412.92M473.03M476.06M477.69M476.24M478.81M479.82M480.92M482.18M486.37M487.58M490.18M490.02M497.06M509.04M512.74M
Shares Outstanding (Diluted Average) 87.83M242.63M248.13M88.69M376.17M408.16M414.57M412.92M473.03M476.06M477.69M476.24M478.81M479.82M480.92M482.18M486.37M495.18M490.18M490.02M497.06M509.04M512.74M
EBITDA -26.44M5.01M12.15M-127.14M-48.91M-317.54M-34.72M-188.53M-80.81M-105.46M-77.90M-82.84M-70.26M-28.50M-39.83M-67.77M-19.36M7.71M-6.04M-24.53M0.24M-10.33M-24.08M
Interest Expenses 7.82M8.48M9.27M10.43M1.18M1.21M0.40M0.40M0.40M0.39M0.40M0.14M0.01M